All Posts

Check out our performance post for detailed info regarding the performance of our model portfolios. Keep in mind that our model portfolios are actual brokerage accounts, we put our own money at risk in these model portfolios because we are biopharma stock investors ourselves. Read more here. If you believe you may be an accredited investor and/or qualified purchaser under SEC rules, and would like to receive future updates if we continue exploring a potential private fund str

We provide the tickers and quarterly targets for each ticker in each portfolio here. And we provide the stocks that were newly added or closed out of the latest quarter for each fund here. Thus, we make it easy for you to identify stocks to consider for your own portfolio, as well as stocks that might be more or less interesting to you each quarter. Use our portfolio upgrader tool to change your portfolio so that it is closer to one of our model portfolios. If you believe you

Summary Since 2023, BPIQ model portfolios built around biopharma hedge-fund consensus holdings have consistently outperformed the biotech benchmarks XBI and IBB. Want access to our portfolio holdings and other portfolios info/tools to help you make better biopharma investment decisions? Sign up for Elite or APEX today? Background We launched our first consensus-based portfolio (Top 20s) on 4/1/2023 and, by 9/30/2023, applied the hedge-fund favorites framework across the rest

Summary

The BPIQ portfolios are a set of portfolios of public biopharma company tickers and target values. The values are set at 45-60 days after each quarter starts for each portfolio, except the Run-Up portfolio. The strategies are based on extensive back-testing that we performed on different strategies based on top holdings of biopharma-focused hedge funds. We identified top strategies that out-performed XBI for many back-tested time frames. Our portfolios are based at least in p

The Amp Bioresearch team goes over some basics on biotech companies and guidelines for understanding and investing in this space. Jumpstart your due diligence with our full database of upcoming catalyst events including which may be biggest movers (30-day free trial risk free): https://www.bpiq.com/ Presentation Outlines 01 - Clinical 02 - Regulatory 03 - Commercial 04 - Financial 05 - Risks ITCI, AMRN, AIMT, ZGNX, BHVN, ARQL, ACST, AXSM, EPZM, HRTX, FGEN, GBT

In this video we go over clinical trials and how they relate to investing in these clinical stage biotech / biopharma companies. Manny Vacchiano with the BiopharmIQ team goes over: - Overview of clinical trial path - Variations and nuances - Reporting out data - Risk Discover 100's of upcoming catalyst events on our biopharma research platform (free 30 day trial no cc required) : https://www.bpiq.com/ Catalyst events, biotech investing, stocks, due diligence, FDA, catalyst ca

Summary

Summary Hedge fund holdings can help you discover new investment ideas We identified & follow the top biopharma-focused hedge funds Q3 hedge fund holdings reports were released on ~11/14/25 This report focuses on top holdings of top biopharma hedge funds as of 09/30/25 Top Biopharma Hedge Funds At BPIQ we identified the top smid-cap biopharma-focused hedge funds ^1. We updated our database of holding and other info re: these funds with their recently-released data for holdings

In this video we go over how to find and analyze biopharma stock catalyst events. Manny Vacchiano with the BiopharmIQ team goes over: - Identifying catalyst events - Finding data & information - Analyzing events and info Discover 100's of upcoming catalyst events on our biopharma research platform (free 30 day trial no cc required) : https://www.bpiq.com/ Catalyst events, biotech investing, stocks, due diligence, FDA, catalyst calendar, biopharm, biopharma, catalyst, biotech,